doi: 10.1007/s11064-017-2250-8 233 ShiLZhangZLiLHolscherC
This duality reflects the complexity of cellular quality control pathways in cancer and underscores their significance as both pathogenic drivers and therapeutic targets
This complex then crosses the inner membrane via a translocase protein
Albert Goday has received fees for investigation projects, consulting, and postgraduate training, and has participated in clinical trials sponsored by Almirall, Ascensia, Colegio de Farmacuticos de Barcelona, Esteve, Federacin Farmacutica, Fundacin Catalana Sndrome de Down, Fundaci Gol i Gorina, Instituto de Salud Carlos III, Jansen, Lilly, Menarini, MSD, Mutuam, Novo Nordisk, Pronokal, RedGDPS, Rovi, Sanofi Aventis
Eli Lilly is making a preemption argument, saying that the FDA approved warning labels for Trulicity and its other GLP-1 drugs, so the company cannot be held legally liable